A Jury Has Found Takeda Negligent in A Second Actos Lawsuit TrialTakeda Pharmaceuticals has lost 2 trials. Juries seem to be convinced that the manufacturer not has acted responsibly in warning physicians and consumers of the link between its diabetes drug, Actos, and bladder cancer. A Maryland state court jury recently decided to have Takeda pay $1.7 million in damages to the family of a former U.S. Army translator who died of bladder cancer in 2012. Unfortunately and additional verdict found the plaintiff did not to exercise reasonable and ordinary care for his own health and safety, and that his failure was a substantial factor in causing him to develop bladder cancer. That finding required the judge to immediately overturn the verdict. A guilty verdict in the first Actos trial was also nullified by the judge, though that ruling is being appealed. As more Actos lawsuits are filed it becomes clear that Actos causes bladder cancer. In May of 2012, a study of people with type 2 diabetes, published in the British Medical Journal, found that use of Actos nearly doubles the rate of bladder cancer. Over extended periods of time. a cumulative dosage appears to have a strong connection to a bladder cancer diagnosis. More than 2,500 suits have been consolidated before a federal judge in a Louisiana MDL and the first of those cases will go to trial in January 2014.
Tags: Actos and bladder cancer, Actos lawsuit, Actos Lawyers, Boston, Charleston, Charlotte, Daytona, Deerfield Beach, Fort Myers, Ft Lauderdale, Gainesville, Jacksonville, Lakeland, Miami, Naples, Ocala, Orlando, Panama City, Pensacola, Raleigh, Tallahassee, The Villages, Venice, West Palm Beach, West Palm beach Actos Bladder cancer lawyer, West palm beach Actos lawyer, West palm beach Bladder cancer lawsuit, Xarelto lawyer